Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease

ClinicalTrials.gov ID: NCT06544616

Public ClinicalTrials.gov record NCT06544616. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 28, 2026, 4:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study, to Assess Efficacy, Safety and Immunogenicity of JNJ-64042056, a Phosphorylated Tau Targeted Active Immunotherapy, in Participants With Preclinical Alzheimer's Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess whether JNJ-64042056 affects the spread and build up of tau (a protein in brain) when compared with placebo, using brain scan (tau PET) to determine results from specific areas of the brain.

Study identification

NCT ID
NCT06544616
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Enrollment
55 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
55 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 21, 2024
Primary completion
Dec 21, 2026
Completion
Jan 4, 2027
Last update posted
Sep 24, 2026

2024 – 2027

United States locations

U.S. sites
34
U.S. states
16
U.S. cities
34
Facility City State ZIP Site status
Xenoscience Inc. Phoenix Arizona 85004 —
Irvine Clinical Research Irvine California 92614 —
Esperanza Clinical Murrieta California 92562 —
Artemis Institute for Clinical Research Riverside Riverside California 92503 —
Artemis Institute for Clinical Research San Diego San Diego California 92123 —
Yale University School Of Medicine New Haven Connecticut 06510 —
JEM Research LLC Atlantis Florida 33462 —
Excel Medical Clinical Trials, LLC Boca Raton Florida 33434 —
K2 Medical Research Winter Garden Clermont Florida 34711 —
Clinical NeuroScience Solutions Inc Jacksonville Florida 32256 —
K2 Medical Research Lady Lake Lady Lake Florida 32159 —
K2 Medical Research Maitland Maitland Florida 32751 —
Merritt Island Medical Research, LLC Merritt Island Florida 32952 —
Headlands Research Orlando Orlando Florida 32806 —
Alzheimers Research and Treatment Center Stuart Stuart Florida 34996 —
K2 Medical Research Tampa Tampa Florida 33634 —
Charter Research The Villages Florida 32162 —
Alzheimers Research and Treatment Center Wellington Wellington Florida 33414 —
Palm Beach Neurology and Premier Research Institute West Palm Beach Florida 33407 —
Great Lakes Clinical Trials Chicago Chicago Illinois 60640 —
Great Lakes Clinical Trials Gurnee Gurnee Illinois 60031 —
Quest Research Institute Farmington Hills Michigan 48334 —
Hattiesburg Clinic Hattiesburg Mississippi 39401 —
The Cognitive and Research Center of New Jersey LLC Springfield New Jersey 07081 —
Neurological Associates of Albany, PC Albany New York 12208 —
Velocity Clinical Research East Syracuse East Syracuse New York 13057 —
The Medical Research Network, LLC New York New York 10128 —
AMC Research, LLC Matthews North Carolina 28105 —
Valley Medical Research Centerville Ohio 45459-2785 —
Keystone Clinical Studies LLC Plymouth Meeting Pennsylvania 19462 —
Butler Hospital Providence Rhode Island 02906 —
Clinical Trials of Texas Inc San Antonio Texas 78229 —
Memory Clinic Inc Bennington Vermont 05201 —
University of Virginia Charlottesville Virginia 22903 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 56 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06544616, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 24, 2026 · Synced Sep 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06544616 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →